|
|
|||||||||
Ms. Ghafoor is Epidemiologist, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Jemal is Program Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Cokkinides is Program Director, Risk Factor Surveillance, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Smith is a Director of Cancer Screening, American Cancer Society, Atlanta, GA.
Dr. Thun is Vice President for Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA, and Associate Editor for CA.
In this article, the American Cancer Society (ACS) describes trends in incidence, mortality, and survival rates of female breast cancer in the United States by race and ethnicity. It also provides estimates of new cases and deaths and shows trends in screening mammography. The incidence and survival data derive from the National Cancer Institutes Surveillance, Epidemiology, and End Results program; mortality data are from the National Center for Health Statistics. Approximately 211,300 new cases of invasive breast cancer, 55,700 in situ cases, and 39,800 deaths are expected to occur among women in the United States in 2003. Breast cancer incidence rates have increased among women of all races combined and white women since the early 1980s. The increasing rate in white women predominantly involves small (
2 cm) and localized-stage tumors, although a small increase in the incidence of regional-stage tumors and those larger than five cm occurred since the early 1990s. The incidence rate among African American women stabilized during the 1990s for all breast cancers and for localized tumors. African American women are more likely than white women to be diagnosed with large tumors and distant-stage disease. Other racial and ethnic groups have lower incidence rates than do either white or African American women. However, the proportion of disease diagnosed at advanced stage and with larger tumor size in all minorities is greater than in white persons. Death rates decreased by 2.5% per year among white women since 1990 and by 1% per year among African American women since 1991. The disparity in mortality rates between white and African American women increased progressively between 1980 and 2000, so that by 2000 the age-standardized death rate was 32% higher in African Americans. Clinicians should be aware that 63% and 29% of breast cancers are diagnosed at local- and regional-stage disease, for which the five-year relative survival rates are 97% and 79%, respectively. This information, coupled with decreasing mortality rates and improvements in treatment, may motivate women to have regular mammographic and clinical breast examinations. Continued efforts are needed to increase the availability of high-quality mammography and treatment to all segments of the population.
This article has been cited by other articles:
![]() |
A. M. Kucharska-Newton, D. J. Couper, J. S. Pankow, R. J. Prineas, T. D. Rea, N. Sotoodehnia, A. Chakravarti, A. R. Folsom, D. S. Siscovick, and W. D. Rosamond Hemostasis, Inflammation, and Fatal and Nonfatal Coronary Heart Disease: Long-Term Follow-Up of the Atherosclerosis Risk in Communities (ARIC) Cohort Arterioscler Thromb Vasc Biol, December 1, 2009; 29(12): 2182 - 2190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sanchez-Serrano, E. Novella-Maestre, E. Rosello-Sastre, N. Camarasa, J. Teruel, and A. Pellicer Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation{dagger} Hum. Reprod., September 1, 2009; 24(9): 2238 - 2243. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun Cancer Statistics, 2009 CA Cancer J Clin, July 1, 2009; 59(4): 225 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Virnig, N. N. Baxter, E. B. Habermann, R. D. Feldman, and C. J. Bradley A Matter Of Race: Early-Versus Late-Stage Cancer Diagnosis Health Aff., January 1, 2009; 28(1): 160 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vona-Davis, D. P. Rose, H. Hazard, M. Howard-McNatt, F. Adkins, J. Partin, and G. Hobbs Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3319 - 3324. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Magai, N. S. Consedine, B. A. Adjei, D. Hershman, and A. Neugut Psychosocial Influences on Suboptimal Adjuvant Breast Cancer Treatment Adherence Among African American Women: Implications for Education and Intervention Health Educ Behav, December 1, 2008; 35(6): 835 - 854. [Abstract] [PDF] |
||||
![]() |
N. Krieger Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections Int. J. Epidemiol., June 1, 2008; 37(3): 627 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, and M. J. Thun Cancer Statistics, 2008 CA Cancer J Clin, February 20, 2008; (2008) CA.2007.0010v1. [Abstract] [Full Text] |
||||
![]() |
D. L. Hershman, D. Buono, R. B. McBride, W. Y. Tsai, K. A. Joseph, V. R. Grann, and J. S. Jacobson Surgeon Characteristics and Receipt of Adjuvant Radiotherapy in Women With Breast Cancer J Natl Cancer Inst, February 6, 2008; 100(3): 199 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dobbe, K. Gurney, S. Kiekow, J. S. Lafferty, and J. M. Kolesar Gene-expression assays: New tools to individualize treatment of early-stage breast cancer Am. J. Health Syst. Pharm., January 1, 2008; 65(1): 23 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Olsen, S. Chu-Ongsakul, K. E. Brandt, J. R. Dietz, J. Mayfield, and V. J. Fraser Hospital-Associated Costs Due to Surgical Site Infection After Breast Surgery Arch Surg, January 1, 2008; 143(1): 53 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Rose, S. M. Haffner, and J. Baillargeon Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women Endocr. Rev., December 1, 2007; 28(7): 763 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Cronin-Fenton, L. A. Ries, L. X. Clegg, and B. K. Edwards Rising Incidence Rates of Breast Carcinoma With Micrometastatic Lymph Node Involvement J Natl Cancer Inst, July 4, 2007; 99(13): 1044 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Taylor, C. D. Williams, K. H. Makambi, C. Mouton, J. P. Harrell, Y. Cozier, J. R. Palmer, L. Rosenberg, and L. L. Adams-Campbell Racial Discrimination and Breast Cancer Incidence in US Black Women: The Black Women's Health Study Am. J. Epidemiol., July 1, 2007; 166(1): 46 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun Cancer Statistics, 2007 CA Cancer J Clin, January 1, 2007; 57(1): 43 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Moy, D Tu, J. Pater, J. Ingle, L. Shepherd, T. Whelan, and P. Goss Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer Ann. Onc., November 1, 2006; 17(11): 1637 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Setiawan, C. A. Haiman, F. Z. Stanczyk, L. Le Marchand, and B. E. Henderson Racial/Ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1849 - 1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Oktay, A. Hourvitz, G. Sahin, O. Oktem, B. Safro, A. Cil, and H. Bang Letrozole Reduces Estrogen and Gonadotropin Exposure in Women with Breast Cancer Undergoing Ovarian Stimulation before Chemotherapy J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3885 - 3890. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Holford, K. A. Cronin, A. B. Mariotto, and E. J. Feuer Chapter 4: Changing Patterns in Breast Cancer Incidence Trends J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 19 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I.J. Wildschut, T.J. Peters, and C. P. Weiner Screening in women's health, with emphasis on fetal Down's syndrome, breast cancer and osteoporosis Hum. Reprod. Update, September 1, 2006; 12(5): 499 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sonmezer and K. Oktay Fertility preservation in young women undergoing breast cancer therapy. Oncologist, May 1, 2006; 11(5): 422 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Kabe and J. M. Kolesar Role of trastuzumab in adjuvant therapy for locally invasive breast cancer Am. J. Health Syst. Pharm., March 15, 2006; 63(6): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, and M. J. Thun Cancer statistics, 2006. CA Cancer J Clin, March 1, 2006; 56(2): 106 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Son, B. S. Kwak, J. K. Kim, H. J. Kim, S. J. Hong, J. S. Lee, U. K. Hwang, H. S. Yoon, and S. H. Ahn Changing patterns in the clinical characteristics of korean patients with breast cancer during the last 15 years. Arch Surg, February 1, 2006; 141(2): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Jatoi, W. F. Anderson, S. R. Rao, and S. S. Devesa Breast Cancer Trends Among Black and White Women in the United States J. Clin. Oncol., November 1, 2005; 23(31): 7836 - 7841. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rosenberg, L. A. Wise, J. R. Palmer, N. J. Horton, and L. L. Adams-Campbell A Multilevel Study of Socioeconomic Predictors of Regular Mammography Use Among African-American Women Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2628 - 2633. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Tammemagi, D. Nerenz, C. Neslund-Dudas, C. Feldkamp, and D. Nathanson Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer JAMA, October 12, 2005; 294(14): 1765 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kerlikowske, J. Creasman, J. W. T. Leung, R. Smith-Bindman, and V. L. Ernster Differences in Screening Mammography Outcomes Among White, Chinese, and Filipino Women Arch Intern Med, September 12, 2005; 165(16): 1862 - 1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Chlebowski, Z. Chen, G. L. Anderson, T. Rohan, A. Aragaki, D. Lane, N. C. Dolan, E. D. Paskett, A. McTiernan, F. A. Hubbell, et al. Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome J Natl Cancer Inst, March 16, 2005; 97(6): 439 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bosetti, M. Malvezzi, L. Chatenoud, E. Negri, F. Levi, and C. La Vecchia Trends in cancer mortality in the Americas, 1970-2000 Ann. Onc., March 1, 2005; 16(3): 489 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jemal, T. Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, E. J. Feuer, and M. J. Thun Cancer Statistics, 2005 CA Cancer J Clin, January 1, 2005; 55(1): 10 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nyirjesy The Public's Enthusiasm for Cancer Screening JAMA, April 21, 2004; 291(15): 1835 - 1836. [Full Text] [PDF] |
||||
![]() |
A. Jemal, R. C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, E. Ward, E. J. Feuer, and M. J. Thun Cancer Statistics, 2004 CA Cancer J Clin, January 1, 2004; 54(1): 8 - 29. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |